The Food and Drug Administration just approved its most expensive drug ever — a hemophilia B gene therapy from Carlisle Companies (CSL) and UniQure (QURE) — and QURE stock popped Wednesday. X Meanwhil...
The Food and Drug Administration just approved its most expensive drug ever — a hemophilia B gene therapy from Carlisle Companies (CSL) and UniQure (QURE) — and QURE stock popped Wednesday. X Meanwhil...